A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Status:
Recruiting
Trial end date:
2023-10-28
Target enrollment:
Participant gender:
Summary
A phase Ib, open-label platform study of select drug combinations chosen in order to
characterize safety and tolerability of each treatment arm tested and to identify recommended
doses and regimens for future studies.